Study S001421

Evaluation of the Efficacy of Probiotics on Digestive Quality of Life in Patients Initiating GLP-1 Receptor Agonists for the Treatment of Obesity. A Randomized, Double-blind Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07213323
Acronym: PROBIO-GLP1
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: DOUBLE
Status: RECRUITING
Enrollment: 50
Start: 2026-08-05
Primary completion: 2027-12-05
Lead sponsor: Hospices Civils de Lyon
Conditions: Obesity &Amp; Overweight; Digestive Disorders
Interventions: DIETARY_SUPPLEMENT:Probiotics (Natural product); OTHER:Placebo
Results posted: FALSE
Secondary identifiers: OTHER:2025-A01248-41

Registered primary outcomes

Assessment of the Limitation of the impairment in digestive quality of life during the dose escalation of GLP1-RA (semaglutide or tirzepatide) [Every 5 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.